A novel nuclear RNA HSD52 scaffolding NONO/SFPQ complex modulates DNA damage repair to facilitate temozolomide

Nan Sun1, Qun Chen2, Hao Chen3,1

  • 1Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Neuro-Oncology
|December 14, 2024
PubMed
Abstract

Insights

A novel noncoding RNA, HSD52, drives temozolomide (TMZ) resistance in glioblastoma (GBM) by stabilizing NONO/SFPQ interactions. Targeting HSD52 offers a promising strategy to enhance TMZ chemotherapy efficacy in GBM patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Glioblastoma (GBM) treatment faces a major hurdle due to emerging temozolomide (TMZ) resistance.
  • Non-POU domain-containing octamer-binding protein (NONO) and splicing factor proline/glutamine rich (SFPQ) are key nuclear proteins involved in genome stability and gene regulation.
  • The specific role of NONO and SFPQ in GBM's TMZ resistance remains largely unexplored.

Purpose of the Study:

  • To investigate the role of NONO and SFPQ in TMZ resistance in glioblastoma.
  • To identify novel molecular targets for overcoming TMZ resistance in GBM.
  • To explore the therapeutic potential of targeting identified mechanisms to improve GBM treatment outcomes.

Main Methods:

  • RNA-binding protein immunoprecipitation-microarray and RNA microarray were utilized to identify HSD52 in TMZ-resistant and parental GBM cells.
  • In vitro assays, intracranial xenograft, and GBM organoid models were employed to assess HSD52's impact on TMZ resistance.
  • Mechanisms were elucidated using DNA methylation chip, RNA immunoprecipitation, and RNA pull-down assays, with analysis of GBM clinical samples.

Main Results:

  • A novel noncoding RNA, HSD52, was identified and found to be highly expressed in TMZ-resistant GBM, facilitating NONO and SFPQ interaction.
  • HSD52 transcription is upregulated via DNA hypomethylation through H3 ubiquitination attenuation and reduced DNMT1 recruitment.
  • HSD52 promotes NONO/SFPQ complex binding to UFL1 mRNA, enhancing its stability and activating the ATM signaling pathway, ultimately conferring TMZ resistance.

Conclusions:

  • HSD52 plays a critical role in promoting malignant progression and TMZ resistance in glioblastoma.
  • HSD52 facilitates TMZ resistance by stabilizing the NONO/SFPQ complex and activating the ATM signaling pathway.
  • HSD52 represents a promising therapeutic target for overcoming TMZ resistance and improving the clinical efficacy of TMZ chemotherapy in GBM.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Nucleosome Remodeling02:54

Nucleosome Remodeling

Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
9.0K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.4K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.2K
DNA Damage Can Stall the Cell Cycle02:37

DNA Damage Can Stall the Cell Cycle

2.6K
Base-pairing and DNA Repair02:27

Base-pairing and DNA Repair

64.6K